Education
About Us
Working with TipRanks
Follow Us
Meilleure Health International Industry Group Limited (HK:2327)
:2327
2327 Stock Chart & Stats
HK$0.28
-HK$0.01(-3.39%)
At close: 4:00 PM EST
HK$0.28
-HK$0.01(-3.39%)
Day’s Range― - ―
52-Week RangeHK$0.21 - HK$0.32
Previous CloseN/A
Volume54.00K
Average Volume (3M)3.52M
Market Cap
HK$1.04B
Enterprise ValueHK$1.37B
Total Cash (Recent Filing)HK$9.95M
Total Debt (Recent Filing)HK$345.96M
Price to Earnings (P/E)26.0
Beta0.37
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding4,093,756,600
10 Day Avg. Volume6,054,000
30 Day Avg. Volume3,517,820
Financial Highlights & Ratios
PEG Ratio-1.74
Price to Book (P/B)0.99
Price to Sales (P/S)23.42
P/FCF Ratio6.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
EPS GrowthReported EPS growth of ~26% indicates the company has improved per-share profitability despite top-line pressures. Sustained EPS improvement suggests better cost control or capital structure efficiency, supporting longer-term ability to fund operations and strategic initiatives.
Positive Free Cash Flow MaintenanceMaintaining positive free cash flow in recent years gives the business durable internal funding capacity. Positive FCF supports reinvestment in products and distribution, deleveraging or working capital needs and provides a buffer against revenue volatility over the medium term.
Multi-channel Distribution And R&D FocusA multi-channel distribution model plus emphasis on R&D and partnerships reduces dependence on any single sales channel and supports diversified revenue streams. This structural approach can improve market reach, resilience and product differentiation over the coming months.
Bears Say
Sharp Revenue DeclineA near-55% revenue decline is a material structural headwind for scale, margin absorption and market positioning. Sustained top-line contraction limits reinvestment, increases per-unit costs and raises reliance on margin recovery or new product launches to restore durable growth.
Volatile Profitability And MarginsInconsistent gross and net margins indicate operational volatility or shifting product mix. Erratic profitability makes forecasting and long-term planning difficult, weakens pricing power and suggests the company may struggle to sustainably convert revenue into stable earnings.
Decreasing Equity Ratio / Rising LiabilitiesA declining equity ratio signals rising liabilities versus assets, reducing financial flexibility. Higher leverage can restrict the company’s ability to fund R&D, expansion or absorb shocks, and may increase vulnerability to rising borrowing costs or covenant pressures.
Meilleure Health International Industry Group Limited News
2327 FAQ
What was Meilleure Health International Industry Group Limited’s price range in the past 12 months?
Meilleure Health International Industry Group Limited lowest stock price was HK$0.21 and its highest was HK$0.32 in the past 12 months.
What is Meilleure Health International Industry Group Limited’s market cap?
Meilleure Health International Industry Group Limited’s market cap is HK$1.04B.
When is Meilleure Health International Industry Group Limited’s upcoming earnings report date?
Meilleure Health International Industry Group Limited’s upcoming earnings report date is Mar 26, 2026 which is in 29 days.
How were Meilleure Health International Industry Group Limited’s earnings last quarter?
Meilleure Health International Industry Group Limited released its earnings results on Aug 28, 2025. The company reported HK$0.004 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.004.
Is Meilleure Health International Industry Group Limited overvalued?
According to Wall Street analysts Meilleure Health International Industry Group Limited’s price is currently Overvalued.
Does Meilleure Health International Industry Group Limited pay dividends?
Meilleure Health International Industry Group Limited pays a Notavailable dividend of HK$0.002 which represents an annual dividend yield of 2%. See more information on Meilleure Health International Industry Group Limited dividends here
What is Meilleure Health International Industry Group Limited’s EPS estimate?
Meilleure Health International Industry Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Meilleure Health International Industry Group Limited have?
Meilleure Health International Industry Group Limited has 4,093,756,600 shares outstanding.
What happened to Meilleure Health International Industry Group Limited’s price movement after its last earnings report?
Meilleure Health International Industry Group Limited reported an EPS of HK$0.004 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.953%.
Which hedge fund is a major shareholder of Meilleure Health International Industry Group Limited?
Currently, no hedge funds are holding shares in HK:2327
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Meilleure Health International Industry Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.57%
12-Months-Change
Fundamentals
Return on Equity
3.21%
Trailing 12-Months
Asset Growth
5.05%
Trailing 12-Months
Company Description
Meilleure Health International Industry Group Limited
Meilleure Health International Industry Group Limited, an investment holding company, engages in industrial hemp, healthcare-related, trading, agency service, property investment and leasing, and property development businesses in Hong Kong, the People's Republic of China, and internationally. The company is involved in the trading of construction materials; development and sale of residential properties; property investment and leasing activities; and sale of healthcare-related products. It also provides real estate agency services; cannabidiol downstream product application services; health management services, including anti-aging, aesthetic medicine, and other health consulting; and healthcare related product sales agency services. The company was formerly known as U-Home Group Holdings Limited and changed its name to Meilleure Health International Industry Group Limited in March 2017. Meilleure Health International Industry Group Limited is headquartered in Admiralty, Hong Kong.
Meilleure Health International Industry Group Limited (2327) Earnings & Revenues
Technical Analysis
―
Chevalier International Holdings Limited
―
Hong Kong ChaoShang Group Ltd.
―
Aceso Life Science Group Limited
―
Loco Hong Kong Holdings Ltd
―
Options Prices
Currently, No data available
---